Comprehensive Biotherapeutic Analysis: Characterization of ADCs, mAbs, and Peptides with Waters Chemistry, LC, MS, and MALS Solutions – Hosted by Waters

The development and characterization of complex biologics such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), antibody-oligo conjugates (AOC’s) and therapeutic peptides require high-resolution, integrated analytical strategies that can keep pace with evolving regulatory and development demands.

This seminar is designed to help analytical scientists solve challenges in biotherapeutic development and to gain practical insights into simplifying complex workflows, support regulatory compliance, and accelerate drug development.

Join us for a lab demo showcasing how to automate your sample prep with Andrew+ pipetting robot and explore Intact Mass analysis using Waters LC-MS systems and the Waters_connect™ platform.

Enjoy lunch, meet fellow scientists, and get your questions answered live by Waters experts.

AGENDA INCLUDES

• The Conjugate Spectrum: LC-MS Approaches for ADCs, AOCs, and More
• A Practical Guide to SEC for mAb Aggregates, Monomers, Fragments, and Biotherapeutic Peptides
• Protein Stories Told by Light Scattering: Insights from SEC-MALS
• From Sensitive Titer to Aggregates in One Run: Innovative Protein A Columns for Upstream Bioprocessing Decisions with simplified 2D ProA-SEC
• Lab Demo:
  • Fully Automated Biotherapeutic Sample Prep- Andrew+ Pipetting Robot
  • INTACT Mass analysis of Proteins using Waters_ Connect by LC-MS, (BioAccord/ Xevo-MRT) and much more.